Steroids Versus Gabapentin

NCT01495923 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2017-04-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether pharmacotherapy or epidural steroid injections are a better treatment for lumbosacral radicular pain.

142 patients referred to a participating pain clinic with lumbosacral radiculopathy will be randomized in a 1:1 ratio to receive one of two treatments. Half (n=71) of the patients will be allocated to receive an epidural steroid injection (ESI; group I), with an equal number allocated to receive gabapentin (group II). Patients \& evaluating physicians will be blinded. Follow-up will be through 3-months after treatment.

Conditions

  • Sciatica
  • Radiculopathy

Interventions

PROCEDURE

epidural steroid injection

Injection of steroids and local anesthetic into the epidural space

PROCEDURE

Sham epidural steroid injection

Injection of saline into the back muscles

DRUG

Gabapentin

Titration of gabapentin to effect

DRUG

Placebo gabapentin

Titration of placebo gabapentin

Sponsors & Collaborators

  • Walter Reed National Military Medical Center

    collaborator FED
  • Brooke Army Medical Center

    collaborator FED
  • Landstuhl Regional Medical Center

    collaborator FED
  • Washington D.C. Veterans Affairs Medical Center

    collaborator FED
  • United States Naval Medical Center, San Diego

    collaborator FED
  • Case Western Reserve University

    collaborator OTHER
  • Milton S. Hershey Medical Center

    collaborator OTHER
  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Steven P Cohen, MD · Walter Reed Army Institute of Research (WRAIR)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-06-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01495923 on ClinicalTrials.gov